Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSAPREPITANT DIMEGLUMINE vs FRAMYCETIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSAPREPITANT DIMEGLUMINE vs FRAMYCETIN: Safety Overview

Metric	FOSAPREPITANT DIMEGLUMINE	FRAMYCETIN
Total FAERS Reports	888	321
Deaths Reported	118	249
Death Rate	13.3%	77.6%
Hospitalizations	364	134
Average Patient Age	57.0 yrs	55.2 yrs
% Female Patients	50.1%	97.4%
FDA Approval Date	Aug 20, 2020	N/A
Manufacturer	Dr. Reddy's Laboratories Inc.,	N/A
Route	INTRAVENOUS	N/A
Marketing Status	Discontinued	N/A